Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium.

Autor: Martins JP; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Figueiredo P; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Wang S; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Espo E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Celi E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.; Department of Pharmacy, University of Chieti - Pescara 'G d'Annunzio', I-66100, Chieti, Italy., Martins B; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Kemell M; Department of Chemistry, University of Helsinki, FI-00014, Helsinki, Finland., Moslova K; Department of Chemistry, University of Helsinki, FI-00014, Helsinki, Finland., Mäkilä E; Department of Physics and Astronomy, University of Turku, FI-20014, Turku, Finland., Salonen J; Department of Physics and Astronomy, University of Turku, FI-20014, Turku, Finland., Kostiainen MA; Biohybrid Materials, Department of Bioproducts and Biosystems, Aalto University, FI-00076, Aalto, Finland., Celia C; Department of Pharmacy, University of Chieti - Pescara 'G d'Annunzio', I-66100, Chieti, Italy., Cerullo V; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Viitala T; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Sarmento B; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135, Porto, Portugal.; INEB - Instituto de Engenharia Biomédica, University of Porto, 4200-135, Porto, Portugal.; CESPU - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, 4585-116, Gandra, Portugal., Hirvonen J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland., Santos HA; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, FI-00014, Helsinki, Finland.

Publikováno v: Bioactive materials [Bioact Mater] 2021 Aug 10; Vol. 9, pp. 299-315. Date of Electronic Publication: 2021 Aug 10 (Print Publication: 2022).